Principles and Practice of Hemofiltration and Hemodiafiltration

Artificial Organs - Tập 22 Số 1 - Trang 20-25 - 1998
Ingrid Ledebo1
1Gambro Group Renal Care, Lund, Sweden

Tóm tắt

There is growing interest in the convective dialysis therapies, hemofiltration (HF) and hemodiafiltration (HDF). Both require dialysis membranes which are highly permeable to solutes as well as fluid, and in both cases large volumes of ultrafiltration are the condition for convective transport. In HDF the convection is combined with diffusion, and as a consequence, maximum clearance over the entire molecular weight spectrum is achieved. Optimal forms of HDF provide urea clearance 10–15% higher than the corresponding diffusive mode. The larger the solute, the greater is the impact of convection, and β2‐microglobulin (β2m) levels may be up to 70% reduced. Traditional postdilution HF provides high clearance of medium sized and large molecules. Satisfactory clearance of small solutes requires blood flows in excess of 500 ml/min. With access to practically unlimited volumes of substitution solution through on‐line ultrafiltration, predilution HF can now be used. This increases the clearance of small solutes to an acceptable range. For HDF as well as HF, large patient populations consistently treated for longer periods of time are needed to make valid outcome comparisons with other therapies.

Từ khóa


Tài liệu tham khảo

10.1111/j.1525-1594.1995.tb02277.x

Sternby J, 1994, A decade of experience with on‐linehemofiltration/hemodiafiltration., Effective hemodiafiltration: Newmethods, 108, 1

10.1038/ki.1992.203

10.1111/j.1525-1594.1995.tb02276.x

10.1038/ki.1996.441

Von Albertini B, 1984, Performance characteristics of highflux haemodiafiltration., Proceedings of the EDTA-ERA, 21, 447

10.1177/039139889501801110

10.1177/039139889702000206

10.1177/039139888801100308

10.1038/ki.1992.157

Mion M, 1992, Haemodiafiltration in high‐cardiovascular‐risk patients., Nephrol Dial Transplant, 7, 453

WizemannV KramerW KnoppG SychlaM SchmidtH RawerP SchütterleG.Cardiovascular function during hemodialysis hemofiltration hemodiafiltration.In: Schütterle G Wizemann V Seyffart G eds.Hemodiafiltration. Oberursel/Ts: Verlag Hygieneplan 1982:89104.

Hakim RM, 1994, The effect of the dialysis membrane onmortality of chronic hemodialysis patients in the U.S.(abstract)., J Am Soc Nephrol, 5, 451

10.1038/ki.1996.350

Collins A, 1997, High‐efficiency/high‐flux therapies improve patient survival (Abstract)., Nephrology, 3, S406

Von Albertini B, 1996, Long‐term survival outcome with high‐efficiency dialysis: Effects oftime, membrane and reuse (abstract)., J Am Soc Nephrol, 7, 1468

QuellhorstEA.Blood pressure control.In: Henderson LW Quellhorst EA Baldamus CA Lysaght MJ eds.Hemofiltration. Berlin/Heidelberg: Springer‐Verlag 1986:2029.

10.1177/039139889301601204

10.1159/000170328

10.1159/000170119

10.1111/j.1440-1797.1996.tb00169.x

Schaefer K, 1984, Optimum dialysis treatment for patients over 60 years with primary renaldisease., Proceedings of theEDTA-ERA, 21, 510

Quellhorst EA, 1987, Long‐term hemofiltration in “poor risk” patients., Trans Am Soc Artif Intern Organs, 33, 758

10.1038/ki.1992.191

10.1111/j.1440-1797.1996.tb00167.x

10.1111/j.1525-139X.1993.tb00492.x

Thông tin
Thông tin xuất bản

Artificial Organs

Tập 22 Số 1

20-25

Thông tin tác giả